Gokhan Hotamisligil, MD, PhD, Named to Advisory Board

hotamisligil2

Gokhan Hotamisligil, MD, PhD, from the Harvard School of Public Health, has been named one of six members of the newly formed Scientific Advisory Board for biomedical data analysis company, Seven Bridges.

This new advisory board will formalize relationships with leading global experts in genomic medicine, bioinformatics, and cancer research. The board members will also advise on the company’s product designs and strategies for Cloud-based biomedical data analysis, as well as share their knowledge about key challenges and opportunities in the field of genomic research.

Hotamisligil is a 2015 Endocrine Society Laureate Award winner, having received the Roy O. Greep Award for Outstanding Research. In his current capacity, Hotamisligil is the James S. Simmons Professor of Genetics & Metabolism, chair, Department of Genetics & Complex Diseases; director, Sabri Ülker Center for Metabolic Research; and an associate member, Harvard-MIT Broad Institute, Harvard Stem Cell InstituteJoslin Diabetes Center. He earned his MD at Ankara University in Turkey, and his PhD from Harvard University. His research has focused his research efforts on the molecular and genetic basis of common and complex diseases, particularly obesity, diabetes, and heart disease.

His research examines the mechanisms of nutrient sensing and response pathways as they relate to immune and metabolic homeostasis. He is an internationally recognized leader with seminal contributions including the discoveries that defined immunological components of obesity and diabetes, discovery of novel hormones regulating lipid and glucose metabolism, and endoplasmic reticulum as a key organelle regulating cellular and organismic metabolism, and its role in obesity, insulin resistance, and diabetes.

Hotamisligil pursues interdisciplinary paths, collaborations, and industry alliances towards development of novel preventive and therapeutic strategies against chronic metabolic diseases. His work has resulted in over 180 highly cited papers and resulted in multiple patents. He has been recognized with fellowships and awards including Markey, Pew, and AAAS Fellowships, the Outstanding Scientific Accomplishment Award of ADA, Wertheimer Award from IASO, Koç Science Award, TUBITAK Science Award, Roy Greep Award of the Endocrine Society, and the International Danone Prize.

 

You may also like

  • Global Leadership Academy Launches at ENDO 2017

    When researchers and clinicians get to a certain stage in their careers, often their momentum can grow somewhat stagnant. Their education and much of their training is already behind them so the future can be somewhat uncertain. At this stage in many careers, it is time to assume a leadership role. However, for endocrinology professionals,…

  • Endocrine Society Response to Immigration Order

    President Donald Trump signed an executive order on Friday, January 27, limiting refugees into the U.S., barring the citizens of seven countries – Iraq, Iran, Syria, Somalia, Sudan, Libya, and Yemen – from entering the U.S. on any visa category, and, consequently, also creating new barriers to the global exchange of scientific information. The order…

Find more in